PAA 2.78% 17.5¢ pharmaust limited

Ann: PAA completes Phase 1 and files for Orphan Drug Designation, page-428

  1. 2,302 Posts.
    lightbulb Created with Sketch. 2848
    The Association for Frontotemporal Degeneration has a generous funding program to assist in research.

    This one particularly caught my eye. No details on 2024 program timing, but 2023 grants were awarded in March. Up to USD$2M available :

    The Treat FTD Fund

    https://hotcopper.com.au/data/attachments/5915/5915552-d54286112681a6e2ed5fbaa67295b2e0.jpg
    https://hotcopper.com.au/data/attachments/5915/5915555-63b50e7b6e60aa112cd9c833842dc44d.jpg
    https://hotcopper.com.au/data/attachments/5915/5915557-edd6bb66781791b61b5d3519a9c31609.jpg

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
-0.005(2.78%)
Mkt cap ! $85.12M
Open High Low Value Volume
18.0¢ 18.5¢ 17.5¢ $59.53K 337.6K

Buyers (Bids)

No. Vol. Price($)
10 518045 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 34777 2
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.